Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Calmodulin (CaM) Activates PI3K alpha by Targeting the "Soft" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85 alpha
  2. Zhang,Mingzhen; Li, Zhigang; Wang, Guanqiao; Jang,Hyunbum; Sacks, David B.; Zhang, Jian; Gaponenko, Vadim; Nussinov,Ruth
  3. JOURNAL OF PHYSICAL CHEMISTRY B. 2018, Dec 13; 122(49): 11137-11146.
  1. 2.   Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
  2. Chen, X. H.; Peer, C. J.; Alfaro, R.; Tian, T.; Spencer, S. D.; Figg, W. D.
  3. Journal of Pharmaceutical and Biomedical Analysis. 2012, Mar; 62: 140-148.
  1. 3.   A Computational Tool for Quantitative Analysis of Vascular Networks
  2. Zudaire, E.; Gambardella, L.; Kurcz, C.; Vermeren, S.
  3. Plos One. 2011, Nov; 6(11): 12.
  1. 4.   Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates
  2. Nwe, K.; Bernardo, M.; Regino, C. A. S.; Williams, M.; Brechbiel, M. W.
  3. Bioorganic & Medicinal Chemistry. 2010, Aug; 18(16): 5925-5931.
  1. 5.   IL-10 helps control pathogen load during high-level bacteremia
  2. Londono, D.; Marques, A.; Hornung, R. L.; Cadavid, D.
  3. Journal of Immunology. 2008 181(3): 2076-2083.
  1. 6.   One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
  2. Lee, K. M.; Lan, Q.; Kricker, A.; Purdue, M. P.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Kang, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Human Genetics. 2007, Dec; 122(5): 525-533.
  1. 7.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 8.   Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome
  2. Pavlovich, C. P.; Grubb, R. L.; Hurley, K.; Glenn, G. M.; Toro, J.; Schmidt, L. S.; Torres-Cabala, C.; Merino, M. J.; Zbar, B.; Choyke, P.; Walther, M. M.; Linehan, W. M.
  3. Journal of Urology. 2005, MAY; 173(5): 1482-1486.
  1. 9.   Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
  2. Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Sarafandi, A. A.; Sein, T.; Mickiene, D.; Bacher, J.; Groll, A. H.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2004, OCT; 48(10): 3959-3967.
  1. 10.   Residues 207, 216, and 221 and the catalytic activity of mGSTA1-1 and mGSTA2-2 toward benzo a pyrene-(7R,8S)-diol- (9S,10R)-epoxide
  2. Gu, Y. J.; Xiao, B.; Wargo, H. L.; Bucher, M. H.; Singh, S. V.; Ji, X. H.
  3. Biochemistry. 2003 42(4): 917-921.
  1. 11.   Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis
  2. Kullberg, M. C.; Jankovic, D.; Gorelick, P. L.; Caspar, P.; Letterio, J. J.; Cheever, A. W.; Sher, A.
  3. Journal of Experimental Medicine. 2002 196(4): 505-515.
  1. 12.   Mutational consequences on replication of M13 constructs containing isomeric diol epoxide adducts in E. Coli
  2. Sayer, J. M.; Kroth, H.; Yagi, H.; Kalena, G.; Jerina, D. M.; Ramos, L. A.; Dipple, A.; Ponten, I.; Goodman, M. E.
  3. Polycyclic Aromatic Compounds. 2002 22(3-4): 871-879.
  1. 13.   Testing of new agents in childhood cancer preclinical models: Meeting summary
  2. Houghton, P. J.; Adamson, P. C.; Blaney, S.; Fine, H. A.; Gorlick, R.; Haber, M.; Helman, L.; Hirschfeld, D.; Hollingshead, M. G.; Israel, M. A.; Lock, R. B.; Maris, J. M.; Merlino, G.; Patterson, W.; Reynolds, C. P.; Shannon, K.; Yu, A.; Yu, J.; Smith, M. A.
  3. Clinical Cancer Research. 2002 8(12): 3646-3657.
  1. 14.   Helicobacter hepaticus-induced colitis in interleukin-10- deficient mice: Cytokine requirements for the induction and maintenance of intestinal inflammation
  2. Kullberg, M. C.; Rothfuchs, A. G.; Jankovic, D.; Caspar, P.; Wynn, T. A.; Gorelick, P. L.; Cheever, A. W.; Sher, A.
  3. Infection and Immunity. 2001 69(7): 4232-4241.
  1. 16.   Crystal structure analysis of recombinant human uteroglobin and molecular modeling of ligand binding
  2. Pattabiraman, N.; Matthews, J. H.; Ward, K. B.; Mantile-Selvaggi, G.; Miele, L.; Mukherjee, A. B.
  3. Uteroglobin/Clara Cell Protein Family. 2000; 923 : 113-127.
  1. 18.   Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts
  2. Ponten, I.; Sayer, J. M.; Pilcher, A. S.; Yagi, H.; Kumar, S.; Jerina, D. M.; Dipple, A.
  3. Biochemistry. 2000 39(14): 4136-4144.
  1. 19.   Novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice
  2. Fox, J. G.; Gorelick, P. L.; Kullberg, M. C.; Ge, Z. M.; Dewhirst, F. E.; Ward, J. M.
  3. Infection and Immunity. 1999 67(4): 1757-1762.
  1. 20.   Uteroglobin: a novel cytokine?
  2. Mukherjee, A. B.; Kundu, G. C.; Mantile-Selvaggi, G.; Yuan, C. J.; Mandal, A. K.; Chattopadhyay, S.; Zheng, F.; Pattabiraman, N.; Zhang, Z.
  3. Cellular and Molecular Life Sciences. 1999 55(5): 771-787.
  1. 21.   Effect of Single Benzo
  2. Lipinski, L. J.; Ross, H. L.; Zajc, B.; Sayer, J. M.; Jerina, D. M.; Dipple, A.
  3. International Journal of Oncology. 1998 13(2): 269-273.
  1. 22.   Dna Adduct Formation By Polycyclic Aromatic Hydrocarbon Dihydrodiol Epoxides
  2. Szeliga, J.; Dipple, A.
  3. Chemical Research in Toxicology. 1998 11(1): 1-11.
  1. 23.   The effect of flavonoids on DMBA-DNA adduct formation in MCF-7 human breast cancer cells
  2. Ciolino, H. P.; Yeh, G. C.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A3890.
  1. 24.   Active Site Architecture of Polymorphic Forms of Human Glutathione S-Transferase P1-1 Accounts For Their Enantioselectivity and Disparate Activity in the Glutathione Conjugation of 7-Beta,8-Alpha-Dihydroxy-9-Alpha,10-Alpha-Oxy-7,8,9,10-Tetrahydroben Zo(a)Pyrene
  2. Hu, X.; Odonnell, R.; Srivastava, S. K.; Xia, H.; Zimniak, P.; Nanduri, B.; Bleicher, R. J.; Awasthi, S.; Awasthi, Y. C.; Ji, X. H.; Singh, S. V.
  3. Biochemical and Biophysical Research Communications. 1997 235(2): 424-428.
  1. 25.   Mechanism of Differential Catalytic Efficiency of Two Polymorphic Forms of Human Glutathione S-Transferase P1-1 in the Glutathione Conjugation of Carcinogenic Diol Epoxide of Chrysene
  2. Hu, X.; Ji, X. H.; Srivastava, S. K.; Xia, H.; Awasthi, S.; Nanduri, B.; Awasthi, Y. C.; Zimniak, P.; Singh, S. V.
  3. Archives of Biochemistry and Biophysics. 1997 345(1): 32-38.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel